1. Home
  2. DH vs CYPH Comparison

DH vs CYPH Comparison

Compare DH & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definitive Healthcare Corp.

DH

Definitive Healthcare Corp.

HOLD

Current Price

$0.81

Market Cap

90.9M

Sector

Technology

ML Signal

HOLD

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$0.69

Market Cap

73.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DH
CYPH
Founded
2011
2011
Country
United States
United States
Employees
N/A
6
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.9M
73.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DH
CYPH
Price
$0.81
$0.69
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$3.08
N/A
AVG Volume (30 Days)
607.8K
2.6M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
63.28
N/A
EPS
N/A
N/A
Revenue
$241,521,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$0.49
52 Week High
$4.70
$3.70

Technical Indicators

Market Signals
Indicator
DH
CYPH
Relative Strength Index (RSI) 48.87 46.92
Support Level $0.80 $0.58
Resistance Level $1.04 $0.81
Average True Range (ATR) 0.08 0.07
MACD 0.01 0.02
Stochastic Oscillator 58.71 62.01

Price Performance

Historical Comparison
DH
CYPH

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Share on Social Networks: